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a b s t r a c t
The fracture healing research, which has been performed in mammalian models not only for clinical
application but also for bone metabolism, revealed that generally osteoblasts are induced to enter the
fracture site before the induction of osteoclasts for bone remodeling. However, it remains unknown how
and where osteoclasts and osteoblasts are induced, because it is difﬁcult to observe osteoclasts and
osteoblasts in a living animal. To answer these questions, we developed a new fracture healing model by
using medaka. We fractured one side of lepidotrichia in a caudal ﬁn ray without injuring the other soft
tissues including blood vessels. Using the transgenic medaka in which osteoclasts and osteoblasts were
visualized by GFP and DsRed, respectively, we found that two different types of functional osteoclasts
were induced before and after osteoblast callus formation. The early-induced osteoclasts resorbed the
bone fragments and the late-induced osteoclasts remodeled the callus. Both types of osteoclasts were
induced near the surface on the blood vessels, while osteoblasts migrated from adjacent ﬁn ray.
Transmission electron microscopy revealed that no signiﬁcant rufﬂed border and clear zone were
observed in early-induced osteoclasts, whereas the late-induced osteoclasts had clear zones but did not
have the typical rufﬂed border. In the remodeling of the callus, the expression of cox2 mRNA was up-
regulated at the fracture site around vessels, and the inhibition of Cox2 impaired the induction of the
late-induced osteoclasts, resulting in abnormal fracture healing. Finally, our developed medaka fracture
healing model brings a new insight into the molecular mechanism for controlling cellular behaviors
during the fracture healing.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The fracture healing process, in which damaged bony tissues
are healed, has been analyzed to reveal the coordination system
held with a variety of cells and molecules. The healing process is
divided histologically into four stages: inﬂammation, soft callus
formation, hard callus formation, and bone remodeling. In each
step, some speciﬁc cells and molecules are induced to form the
environment for healing (Schindeler et al., 2008). These steps
overlap each other, and it is difﬁcult to separate them. The healing
is controlled by a balance between the catabolism removing
damaged tissues, and the anabolism forming new tissues, which
is regulated primarily by osteoclasts and osteoblasts.
Osteoclasts are bone resorbing cells that work catabolically to
remodel the callus, and osteoblasts are bone forming cells that
function anabolically to calcify fractured bones to form the callus.
Their differentiation mechanisms have been analyzed in vivo and
in vitro. Osteoblasts are differentiated from mesenchymal stem
cells by transcriptional regulation effected with runx2 and osterix
(Karsenty et al., 2009). In the fracture healing, osteoblast progeni-
tors are implied to come from various sources like circulation
(Pignolo and Kassem, 2011) and periosteum (Malizos and
Papatheodorou, 2005), but their migration and differentiation in
the fractured tissues have not been shown. On the other hand,
osteoclasts are differentiated from hematopoietic stem cells via
macrophage colony stimulating factor (M-CSF) and receptor acti-
vator of NF-κB ligand (RANKL) signaling by osteoblasts (Kong et al.,
1999; Yasuda et al., 1998). Osteoclasts progenitors possibly come
from circulation (D'Amelio et al., 2010) or bone marrows
(Tsujigiwa et al., 2013), but their migration and differentiation
have not been demonstrated too. Taken together, how and where
osteoclasts and osteoblasts are induced remains obscure in ortho-
pedics. To answer this question, in vivo analysis, such as live-
imaging analysis, is recommended.
Here in this study, we used medaka caudal ﬁn to observe the
fracture healing process in living animals. Recently, medaka is
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considered as a well-developed model animal for the study of
bone development (Chatani et al., 2011; To et al., 2011; Willems
et al., 2012). Among bone tissues, the caudal ﬁn ray is thin and
transparent which properties lead the live-imaging analysis by
using various transgenic medaka, in which osteoclasts and osteo-
blasts are labeled with ﬂuorescence (Chatani et al., 2011; Inohaya
et al., 2010). The bony ﬁn ray consists of a pair of segmented
convex hemirays (lepidotrichia) (Nakatani et al., 2007). In this
study, one of the paired lepidotrichia is fractured with a minor
damage of surrounding soft tissues.
In the mammalian models, a major damage against surrounding
soft tissues and blood vessels cannot be avoided. A blood vessel is
known as one of the sources of osteoclasts and osteoblasts (Schindeler
et al., 2008). In this model, cell induction and migration are especially
observed without the concern of cells being released due to destruc-
tion of blood vessels. In addition, inﬂammation is essential for
induction of osteoclasts and osteoblasts. Cyclooxygenase-2 (cox2),
one of the inﬂammation signals, is reportedly crucial to regulate
fracture healing (Simon et al., 2002). Our model enables to observe the
inﬂuence of minimally limited inﬂammation.
In this present study, we created a new fracture healing model
which allows live fracture healing observation in living animals.
Osteoclasts and osteoblasts behaviors are observed in this model
during fracture healing by using the transgenic medaka. This is the
ﬁrst report demonstrating osteoclast and osteoblast live-behavior.
Our data revealed that two types of different functional osteoclasts,
Fig. 1. The structure of medaka ﬁn ray and osteoblast localization. (A) Lateral view of the caudal ﬁn of an adult medaka. (B) Cross-section of a ﬁn ray. The section was stained
with methylene blue (MB). Magniﬁed views of the areas denoted by the black-dotted rectangle are shown at the right (a, b). The ﬁn ray is composed of a pair of bones
covered with a single layer of ﬂat cells (black arrowheads). (C) Magniﬁed view of ﬁn ray composed of segmented bony tissue in a double Tg (osterix:GFP/TRAP:DsRed). osterix-
GFP positive osteoblasts are located on the ﬁn ray (black arrowhead), but no TRAP-DsRed positive osteoclasts are found in the medaka caudal ﬁn. (D) Tartrate-resistant acid
phosphatase (TRAP) activity staining of a cross-section. No TRAP-activity positive cells are detected. (E) Z-stack image of a ﬁn ray in a Tg (osterix:GFP) stained with Alizarin
complexone (ALC). Cross view at the level of the white-dotted line is shown below. osterix-GFP positive osteoblasts are lined along the edge (lower panel, white arrowheads), and
are sprinkled on the middle outer surface of the ﬁn ray (lower panel, white arrows). (F) Z-stack image of a Tg (osteocalcin:DsRed) stained with calcein. Cross view at the level of the
white-dotted line is shown below. osteocalcin-DsRed positive osteoblasts are sprinkled on the middle outer surface of the ﬁn ray (lower panel, white arrows), but not at the edge of
the ﬁn ray. (G) Z stack image of a ﬁn ray in the double Tg (osterix:GFP/osteocalcin:DsRed). The osteocalcin-DsRed positive osteoblasts are merged with the osterix-GFP positive
osteoblasts (white arrows). The anatomical orientation is shown in A, B, C and E. The scale bars represent 1 mm (A), 100 μm (B, C, D, E, Ea, b, F) and 10 μm (Ba, b).
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the early- and the late-induced osteoclasts, were induced before and
after the osteoblast callus formation, and Cox2 regulated the appear-
ance of the late induced-osteoclasts for bone remodeling.
Materials and methods
Fish strains and maintenance
The medaka Cab strain was utilized as the wild type for all
studies. Fish were kept under a photoperiod of 14 h light/10 h
darkness at 28 1C. Eggs were obtained by random crossing and kept
at the same temperature. Embryos were incubated at 30 1C after
collection, and staged as previously reported (Iwamatsu, 2004). After
hatching, the larvae were incubated at room temperature.
Fracturing bone in the caudal ﬁn
A sharp-edged glass capillary was made from a glass capillary
(GD1, NARISHIGE) by using a glass puller (PC-10, NARISHIGE).
Employing adult ﬁsh at 3–6 months old, we fractured one of the
paired lepidotrichia at the 2 segments before branch in a caudal ﬁn
ray, and left the other one in its normal state (Fig. 2A–C).
cDNA cloning of medaka cyclooxygenase-2 (cox2)
The medaka cox2 gene was ampliﬁed by using the following
primers, which were designed on the basis of Ensemble genome
browser: cox2 promoter F, 50-TAATCCGT GTTGCTCATGGCC-30 and
R, 50-TGACATCTGCTAGGCGAGAGC-30.
Fig. 2. Fracture healing of medaka caudal ﬁn. Schematic drawing of the medaka ﬁn ray (A–C) and Alizarin red and Alcian blue staining of the fractured ﬁn ray (D–H) are shown.
(A) Lateral-view of the medaka ﬁn ray. The ﬁn ray is a segmented bony tissue. There are blood vessels inside and outside the ﬁn ray. (B) Cross-view at the level of the black-dotted
line in “A”. The blood vessel inside the ﬁn ray is an artery (black arrow) and others outside the ﬁn ray are veins (black arrowheads). Osteoblasts are located on the outer surface of
the ﬁn ray, especially at the edge of the outer surface. (C) Cross view of the fracture operation with glass capillary. One side of the ﬁn ray is fractured with a glass capillary, and the
other is left intact. (D) One of the paired bones is fractured. (E) Alcian blue-positive tissue (black arrow) is observed around the fracture site at day 4 after the fracturing. Bone
fragments remain sharp (black arrowhead). (F) The sharp bone fragments become round at day 8 (black arrowheads), and the Alcian blue-positive tissue changes to Alizarin red-
positive tissue (black arrow). (G) Alcian blue-positive tissue is no longer observed at day 12, and the fracture site is covered with an Alizarin red-positive rough-surfaced callus
(black arrows). (H) The rough-surfaced callus becomes a smooth shape by day 24. The anatomical orientation is shown in A, B and D. The scale bars represent 100 μm.
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Semi-quantitative RT-PCR
Total RNA (2 μg) from each sample was reverse-transcribed in a
volume of 20 μl by using a cDNA reverse transcription kit (Takara).
The following medaka speciﬁc semi-quantitative RT-PCR primers
for cox2 were designed on the basis of Ensemble genome browser:
cox2 F, TAATCCGTGTTGCTCATGGCC and cox2 R, TGTGTGATC GA-
GATGTCAGC. The reported medaka RANKL amino acid sequence
(To et al., 2011) was used to identify the RANKL gene location on
Ensemble genome browser. The following medaka speciﬁc semi-
quantitative RT-PCR primers for RANKL, which can detect all splice
variants, were designed: RANKL F, TGTTCCAGTATTTCTACCGT and
RANKL R, TCAGTTGCCCAGCTTTATGG. The medaka speciﬁc β-actin
primers for the semi-quantitative RT-PCR (Fujimori et al., 2010)
were used as controls. The PCR mixture contained 1 Takara
ExTaq buffer, 0.2 mM dNTP mix, 0.5 units Takara ExTaq, 10 pmol of
each primer, and 0.5 μl of sample cDNA. Reactions were carried out
at 94 1C for 3 min, followed by 20 cycles for cox2 or 23 cycles for
RANKL in the condition of 15 s at 95 1C, 30 s at 55 1C, and 1 min
at 72 1C.
Generation of the transgenic medaka
To generate cox2 promoter GFP transgenic medaka, Tg (cox2:
GFP), the 3-kb upstream regulatory region of the medaka cox2
gene was ampliﬁed for generating the Tg (cox2:GFP) by using the
following primers: cox2 promoter F-KpnI, 50-ACAGCTATCCATCA
GCCACTG-30; and cox2 promoter R-ApaI, 50-GCTCCTGAGTTT-
GATCTTTTGC-30. The ampliﬁed fragment was cloned into the TA
cloning vector. We then digested the fragment with KpnI and ApaI,
and subcloned it into the KpnI/ApaI site of the I-SceI (Thermes
et al., 2002) backbone vector, in which MCS/EGFP/SV40polyA of
pEGFP1 (Clontech) was inserted into the HindIII and AﬂII sites of
PBSKI2 (AMAGEN).
For creating the ﬂi1 promoter DsRed transgenic medaka, Tg
(ﬂi1:DsRed), the 4.6-kb upstream region of the medaka ﬂi1 gene
was ampliﬁed by using the following primers: ﬂi1 promoter
F-XhoI, 50-TGTGTCCTGAATGTCCTGAC-30; and ﬂi1 promoter R-KpnI,
50-TTTGCGCAAATTTTCGCGGACC. The digested fragment with XhoI
and KpnI was subcloned into the XhoI/KpnI site of the I-SceI
backbone vector, in which MCS/DsRed Express/SV40polyA of
pDsRed Express (Clontech) was inserted into HindIII and AﬂII sites
of PBSKI2 (AMAGEN).
Whole-mount RNA in situ hybridization
Samples were ﬁxed in 4% PFA overnight at 4 1C. Whole-mount
RNA in situ hybridization was performed as previously described
with digoxigenin-UTP-labeled RNA probes for cox2 (Katogi et al.,
2004).
Bony tissue staining
In vivo bone staining was performed as previously described
(Chatani et al., 2011). Medaka caudal ﬁns were ﬁxed overnight at
4 1C with 4% PFA in PBS for Alizarin red and Alcian blue staining.
Staining was performed as previously described (Ohisa et al.,
2010).
Histological analysis
Adult ﬁns were cut off and ﬁxed with 4% PFA in PBS overnight
at 4 1C, dehydrated by ethanol, and embedded in liquid resin
(Technovit8100, Kulzer Heraeus) with coagulant (Hater, Kulzer
Haraeus). For detecting ﬂuorescence signals of GFP and DsRed, the
transgenic ﬁns were dehydrated by technovit8100 instead of
ethanol (Takano et al., manuscript in preparation). Sections were
cut at 4 μm. Staining for TRAP activity was performed as previously
reported (Chatani et al., 2011).
Confocal laser scanning microscopic analysis in vivo
Adult ﬁsh were anesthetized with 3-amino benzoic acid ethyl
ester and laid on 1.5% agar (Agar powder, Nacalai). The caudal ﬁn
was then covered with 1.5% low-melting temperature agarose and
observed under a confocal laser scanning microscope (FV1000,
Olympus) equipped with 20 water (NA¼0.5) and 60 water
(NA¼0.9) objectives for the 488 nm, 543 nm and 653 nm laser
lines. Obtained data were analyzed by use of FluoRender (Wan
et al., 2009).
Three-color imaging of osteoclasts, osteoblasts, and bone
To observe osteoclasts, osteoblasts, and bone simultaneously,
we employed the double Tg (osterix:GFP/TARP:DsRed). The bone
was stained with alizarin complexone (ALC) for 1 day before
observation with a confocal scanning laser microscope. GFP
absorbs the 488-nm laser line, DsRed absorbs the 543-nm laser
line, and ALC absorbs both 543-nm and 653-nm laser lines.
Fluorescence emitted by 488-nm, 543-nm, and 653-nm laser lines
were colorized green, red, and blue, respectively. By this method,
osteoblasts (green), osteoclasts (red), and bone (purple) could be
observed separately.
Live imaging of osteoblasts
Tg (osterix:GFP) was employed to observe osteoblast migration
to the fracture site. Fish were put under anesthetic by 0.002%
tricaine (Sigma). A ﬁn was embedded into the 1.5% low melting
point agars gel (SeaPlaque GTG Agarose, CAMBREX) and observed
by a confocal laser-scanning microscope with 20 water immer-
sion objective. Observation was performed once in 3 h for 72 h.
Fish were treated in breeding water at 28 1C after each observa-
tion. The data were Z-stacked by FV1-ASW 2.0 viewer (Olympus)
and combined into the movie by photoshop CS4 (Adobe) and quick
time player Pro (Apple).
Induction of cox2 expression by use of TPA
12-O-tetradecanoylphorbol 13-acetate (TPA, Cayman) was used
as a cox2 activator. Wild-type larvae at 3 day post hatching (dph)
were treated for 1 h with 50 ng/ml TPA in breeding water. After a
brief wash with water, the samples were ﬁxed in 4% PFA in PBS for
RNA in situ hybridization. Three-dph Tg (cox2:GFP) larvae were
treated with 5 ng/ml TPA for 1 h. GFP signals were observed under
the ﬂuorescence microscope after a 12 h wash with water.
Chemical inhibition of Cox2 activity
CAY10404 (Cayman) was used as a selective Cox2 inhibitor
(Scherz et al., 2008). Transgenic ﬁsh were treated with 1 μM
CAY10404 in their breeding water, and 0.1 μl/ml DMSO was used
as the control. Treatment with the chemical was started 1 day
before the fracture, and the chemical solution was replaced with
fresh solution every day.
Electron microscopy
Live imaging of Tg (TRAP:GFP) was ﬁrst performed by using a
ﬂuorescence microscope. After the images had been captured, the
medaka ﬁn was ﬁxed in 4% PFA in 0.1 M cacodylate-buffered saline
(pH7.4) overnight at 4 1C. The specimen was trimmed and further
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ﬁxed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer overnight
and post-ﬁxed with 1% osmium tetroxide solution in 0.1 M
cacodylate buffer reduced with 1.5% potassium ferrocyanide for
2 h at 4 1C. The ﬁn was then dehydrated in a graded ethanol series,
substituted with acetone, and embedded in Epon 812 (TAAB,
Berkshire, UK). Ultrathin sections were double-stained with uranyl
acetate and led citrate solutions, and examined under the T-7100
transmission electron microscope (Hitachi, Tokyo, Japan) at an
acceleration voltage of 75 kV).
Results
Localization of osteoclasts and osteoblasts in the ﬁn ray
The medaka caudal ﬁn, which is thin and transparent (Fig. 1A),
is mainly composed of epidermis, mesenchyme, blood vessels, and
bony ﬁn rays. Each ﬁn ray is composed of a pair of lepidotrichia
(Fig. 1B, Fig. 2A and B). To observe osteoblasts and osteoclasts in
the living ﬁsh, we established a double transgenic medaka line
with osterix promoter GFP (Inohaya et al., 2010) and TRAP (Tartrate
Resistant Acid Phosphatase) promoter DsRed (Chatani et al., 2011),
designated as Tg (osterix:GFP/TRAP:DsRed). In the Tg ﬁsh, osterix-
GFP positive osteoblasts were observed on the surface of the ﬁn
ray (Fig. 1C, black arrowhead), whereas TRAP-DsRed positive cells
were not observed. Next, to conﬁrm absence of osteoclasts, we
performed TRAP-activity staining of the caudal ﬁn section. As
expected, no TRAP-activity positive cells were observed (Fig. 1D),
consistent with the ﬁnding that no TRAP-DsRed positive cells were
seen in the caudal ﬁn (Fig. 1C). To further demonstrate osteoblast
localization, we performed 3D imaging analysis of Tg (osterix:GFP)
or Tg (osteocalcin:DsRed) (Inohaya et al., 2007) with a confocal
laser scanning microscope coupled with the cross-section, and
stained the bone with Alizarin complexone (ALC) or calcein (Fig. 1E
and F). osterix is an early differentiation marker of osteoblasts,
whereas osteocalcin-DsRed positive osteoblasts are more mature.
osterix-GFP positive osteoblasts were localized at the edge of the
ﬁn ray (Fig. 1E lower panel, white arrowheads) and on the middle
outer surface of the ﬁn ray (Fig. 1E lower panel, white arrows).
On the other hand, osteocalcin-DsRed positive osteoblasts were
localized only on the middle outer surface (Fig. 1F lower panel,
white arrows). In a double Tg (osterix:GFP/osteocalcin:DsRed),
DsRed and GFP signals were co-localized on the middle outer
surface of the ﬁn ray (Fig. 1G, white arrows).
Creation of the fracture healing model using the ﬁn ray
A cartoon of the fracture model is shown, in which blood
vessels inside and outside the ﬁn ray are the artery and veins,
respectively (Fig. 2A and B). To fracture one of the paired bones
without injuring other tissues or blood vessels, we used a sharp
glass capillary (Fig. 2C). We prevented the damage of the blood
vessels so as to ignore the effect of hematopoietic lineage cells
derived from blood vessels. To carry out this operation to avoid the
damage to blood vessels, we surveyed the damage or destruction
of blood vessels by live imaging. The data in the movie format
demonstrating blood ﬂows before and after fracturing are shown
in Supplementary Movies 1 and 2, with the results being that
blood ﬂows remained normal after fracturing. Moreover, since we
could not exclude a small amount of damage or destruction of
small vessels, by using the double Tg (ﬂi1:GFP/TRAP:DsRed), we
purposely damaged the blood vessels prior to fracture healing and
monitored them by live imaging to examine the induction of
osteoclasts. The results showed no signiﬁcant difference in the
induction of osteoclasts in the fracture healing (Supplementary
Fig. 1), suggesting that for the appearance of osteoclasts, bone
fracture itself but not damaged vessels is important.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.08.007.
Alizarin red and Alcian blue staining was performed at day 0, 4,
8, 12, and 24 during the process of fracture healing (Fig. 2D–H).
Immediately after the fracture, the fractured lepidotrichia was
separated (Fig. 2D). At day 4, the fractured lepidotrichia was
bridged. In the bridged region, Alcian blue-positive tissue was
observed (Fig. 2E, black arrow), whereas newly embedded Alizarin
red-positive calciﬁed tissue was not observed. The fractured bone
fragments remained sharp (Fig. 2E, black arrowhead). At day 8, a
callus, which was covering the fracture site, was observed; and the
fracture fragments had become rounded and embedded in
the callus (Fig. 2F, black arrowheads). The neighboring Alcian
blue-positive area of the callus was partially replaced by Alizarin
red-positive tissue (Fig. 2F, black arrow). At day 12, the Alcian
blue-positive tissue had been replaced by Alizarin red-positive
tissue, and the shape of the callus became gradually smooth
(Fig. 2G, black arrow). By day 24, the Alizarin red-positive callus
had been more remodeled to a relatively smooth surface (Fig. 2H),
although this surface was not restored into the normal one after
two months (data not shown). These data indicate that osteoblasts
were activated by the bone-fracture event and that the fractured
lepidotrichia was repaired by the newly embedded Alizarin
red-positive calciﬁed bone via Alcian blue-positive tissue. In
addition, bone resorption of the fracture fragments and callus, as
evidenced by the rough to smooth transition, was observed. These
data suggest that osteoclasts that do not exist normally in the ﬁn
ray are induced by the bone fracture.
Induction of osteoblasts and osteoclasts during the fracture healing
To perform the live-imaging analysis of osteoclasts and osteo-
blasts, we employed the double Tg (TRAP:DsRed/osterix:GFP),
which displays osteoclasts as DsRed ﬂuorescence and osteoblasts
as GFP ﬂuorescence (Fig. 3). Moreover, to visualize bones in this
transgenic line, we performed ALC staining. The fracture healing
process was examined by using a confocal laser scanning micro-
scope, and the images were analyzed by 3D-rendering software,
FluoRender (Wan et al., 2009), which generated also the cross
section (Fig. 3, lower panels).
By day 3 after fracturing, the bone fracture induced osteoclasts,
which were termed early-induced osteoclasts (Fig. 3A, white
arrowheads). These early-induced osteoclasts were attached pre-
ferentially to the bone fragments, and they were mainly present at
the outside of the ﬁn ray. At day 5, these early-induced osteoclasts
gradually disappeared (Fig. 3B, white arrowheads), whereas the
number of osteoblasts were gradually increased at the fracture site
to form the callus (Fig. 3B, white arrow). At day 7, these osteoblasts
covered the fracture site, and only a few osteoclasts remained
(Fig. 3C). At day 9, the number of osteoblasts peaked (Fig. 3D); and
the osteoclasts were induced again inside the ﬁn ray (Fig. 3D lower
panel, white arrowhead). These osteoclasts were designated as the
late-induced osteoclasts. The number of these osteoclasts gradu-
ally increased, and they covered the callus (Fig. 3E, white arrow-
heads); whereas the number of osteoblasts gradually decreased
(Fig. 3E). By day 25, the late-induced osteoclasts had disappeared;
and the callus had been remodeled to show a relatively smooth
surface (Fig. 3F). These observations indicate that two different
types of functional osteoclasts were induced, one before and the
other after the callus formation by osteoblasts. The early-induced
osteoclasts resorbed the bone fragments, and the late-induced
ones remodeled the callus.
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Histological analysis of the early-induced and late-induced
osteoclasts
To conﬁrm the function and morphology of the early- and late-
induced osteoclasts, we performed histological analysis by applying
cross-sections of the double Tg (TRAP:DsRed/osterix:GFP) at day 3 and
day 11, which include the fracture site or callus (Fig. 4A–D, white
arrowheads). The TRAP-DsRed positive early-induced osteoclasts at
day 3 after fracturing were attached to bone fragments (Fig. 4A,
yellow arrowhead), and osterix-GFP positive osteoblasts were loca-
lized like an arch on the fracture site (Fig. 4A, yellow arrow). No
newly embedded callus was observed at day 3. In addition, when the
TRAP-activity assay was performed on the same section (Fig. 4B), the
TRAP-activity positive cells coincided with the TRAP-DsRed positive
cells (Fig. 4A and B). At day 11 after fracturing, the late-induced
osteoclasts covered the newly embedded callus (Fig. 4C, yellow
arrowheads). The merged images of the same section revealed that
the TRAP-DsRed positive cells were also positive for TRAP activity
(Fig. 4D). The results showed that the TRAP positive region occupied
by the late-induced osteoclasts was larger than that covered by the
early-induced ones (Fig. 4B and D), and that the number of multi-
nucleated osteoclasts with a high nuclear number increased at day 11
(Fig. 4Ca, c, blue arrowheads), compared with that at day 3 (Fig. 4Aa, c,
blue arrowheads). These data suggest that these two types of
osteoclasts had different functions, one for resorbing bone fragments
and the other for remodeling the callus.
Furthermore, transmission electron microscopy (TEM) analysis
was also performed at day 3 and day 12 after fracturing to analyze
cell morphology associated with the repairing of the ﬁn ray of a Tg
(TRAP:GFP) (Fig. 5A and D). At day 3, multinucleated and mono-
nuclear early-induced osteoclasts were observed. These osteo-
clasts had numerous mitochondria in their cytoplasm (Fig. 5B
and C). Mononuclear osteoclasts had attached to the bone frag-
ment, and multinucleated osteoclasts were evident. No signiﬁcant
rufﬂed border and clear zone were observed in these osteoclasts
(Fig. 5C). At day 12, the late-induced osteoclasts appeared; and
they also had many mitochondria in their cytoplasm (Fig. 5E and F).
In the magniﬁed view, these cells had clear zones but did not have
the typical rufﬂed border; only poorly developed rufﬂed border-like
membrane invaginations were occasionally encountered (Fig. 5F).
Moreover, the progressive demineralization of bone matrix by the
osteoclast was found in the surface zone of Howship's lacuna
(Fig. 5G). These data indicate that both types of osteoclasts had a
mitochondrion-rich character and that the late-induced osteoclasts
attached to the bone tightly via the clear zone. In addition,
regarding osteoblasts, these cells were embedded in the bone and
became apoptotic (Supplementary Fig. 2), indicating no osteocyte
formation in medaka; because osteoblasts do not differentiate into
Fig. 3. 3D imaging of osteoclasts, osteoblasts, and bones during the fracture healing. The double Tg (TRAP:DsRed/osterix:GFP) was employed. Bones were stained with ALC.
The 3D-imaged ﬁgures and the cross sections at the level of the white-dotted lines are shown. (A) Early-induced osteoclasts (white arrowheads) attached to the bone
fragments at day 3 after fracturing. They are not found inside the ﬁn ray. (B) Early-induced osteoclasts (white arrowheads) are decreased in number, and osteoblasts (white
arrows) are increased in number at the fracture site at day 5. (C) Osteoblasts calcify the fracture site to form the callus at day 7. In this stage, few early-induced osteoclasts are
observed. (D) At day 9, the number of osteoblasts peaks, and the late-induced osteoclasts (white arrowhead) start to appear at the inside of the ﬁn ray at this time. (E) Late-
induced osteoclasts (white arrowheads) continue to be recruited at day 15. Most of them are attached to the inner surface of the callus, with some attached to the outer
rough surface. (F) By day 25, the fracture site has become completely remodeled, with the callus having a smooth surface. No osteoblasts or osteoclasts are detectable. The
anatomical orientation is shown in A. The scale bars represent 100 μm.
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osteocytes, consistently with the previous report indicating few
osteocytes in medaka bone (Cao et al., 2011).
Cell origin of osteoclasts and osteoblasts
In resin sections, some osteoclasts were observed at the
predicted area of blood vessels apart from the bone fragments
(Fig. 4Aa, b, Ca, b, yellow arrowheads). To examine the positional
relationship between osteoclasts and blood vessels, we used Tg
(ﬂi1:GFP) (Supplementary Fig. 3A and C), since ﬂi1 is a typical
marker of blood vessels (Moriyama et al., 2010). The results
showed that some osteoclasts positive for TRAP-activity staining
were localized along the blood vessels (Supplementary Fig. 3B
and D, white arrow head). These osteoclasts along the blood
Fig. 4. Histological analysis of the early-induced and late-induced osteoclasts. Cross-sections of the fractured ﬁn ray in the double Tg (TRAP:DsRed/osterix:GFP). Magniﬁed
views of the white-boxed area are shown below. (A) Fluorescent image of the section at day 3. Nuclear DNA was stained with TOPRO3. White arrowhead indicates the
fracture site. TRAP-DsRed positive early-induced osteoclasts are attached to the bone fragments (yellow arrowhead). On the other hand, some TRAP-DsRed positive early-
induced osteoclasts are detected at a distance from the bone fragments (a, b, c, yellow arrowheads), and cells with multiple nuclei are seen in some TRAP-DsRed positive
areas (a, c, blue arrowheads). The osterix-GFP positive osteoblasts localize like an arch shape on the outer surface of the fracture site (yellow arrow). Some osterix-GFP
positive cells are detected on the inner surface of the unfractured ﬁn ray (b, yellow arrows), where there are normally no osteoblasts. (B) TRAP-activity staining of the section
shown in “A”. White arrowhead indicates the fracture site. TRAP-DsRed positive cells coincide with TRAP-activity positive cells. (C) Fluorescent image of a section at day 11.
Nuclear DNA was stained by TOPRO3. White arrowhead indicates the callus. TRAP-DsRed positive late-induced osteoclasts cover the callus (yellow arrowheads). Some such
osteoclasts are detected at a distance from the newly embedded callus (a, c, yellow arrowhead), and cells with multiple nuclei are observed in some TRAP-DsRed positive
areas (a, c, blue arrowheads). osterix-GFP positive osteoblasts are observed around the callus (yellow arrows). Some such cells remain on the inner surface of the unfractured
ﬁn ray at the side opposite to the fracture site (b, yellow arrows), but no ectopic calciﬁcation is observed. (D) TRAP-activity staining of the section shown in “C”. White
arrowhead indicates the callus. TRAP-DsRed positive cells coincide with TRAP-activity staining positive cells. The anatomical orientation is shown in A. The scale bars
represent 100 μm (A–D) and 10 μm (Aa, b, c, Ca, b, c).
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vessels were traced by using double transgenic Tg (ﬂi1:GFP,
TRAP:DsRed). As the result, the early-induced osteoclasts
appeared on the blood vessels around the fracture site at day
1 after fracturing (Fig. 6Aa, b, white arrowheads). At day 3,
osteoclasts which cell number was highly increased were found
on the fracture fragments (Fig. 6Ba, b, white arrowheads). At day
7, after the start of callus formation, the late-induced osteoclasts
appeared on the blood vessels (Fig. 6Ca, b, white arrowheads).
At day 12, osteoclasts were found to cover the callus (Fig. 6Da, b,
white arrowheads). These data suggest that both types of
osteoclasts differentiate from cells on the blood vessels and
that after the maturation, they migrate to the bone fragments or
the callus, attracted by unknown factors. Moreover, in the case
of the early-induced osteoclasts, the majority of them appears to
likely have arisen from the veins (Fig. 6A), whereas late
induced-osteoclasts appear to probably come from both of the
Fig. 5. Morphological analysis of the early-induced and late-induced osteoclasts by TEM. (A) Fluorescent view of a Tg (TRAP:GFP) at day 3 after fracturing. (B) TEM image of
the fracture site viewed in sections along the white-dotted line in “A.” The early-induced multinucleated osteoclasts (delimited by the red dotted lines) and a mononuclear
osteoclast (yellow-dotted area) are seen. Inset: semithin section of the fracture site, with the arrows indicating the fractured edges corresponding to “b” in the TEM image.
(C) Magniﬁed view of “B”. There are numerous mitochondria (m) in the cytoplasm of both types of osteoclasts. Note the absence of the typical rufﬂed border and clear zone.
(D) Fluorescent view of a Tg (TRAP:GFP) at day 12 showing late-induced osteoclasts absorbing the callus. (E) Late-induced osteoclasts also have many mitochondria, and these
cells have formed the organelle-free clear zone (cz) while attaching to the callus (c). (F) Magniﬁed view of “E”. Note that the late-induced osteoclasts display a typical clear
zone enriched with actin bundles situated perpendicular to the bone (callus) surface. Some of these cells have indistinct rufﬂed border-like membrane invaginations
(asterisk). (G) Enlarged TEM image of bone resorption site by an osteoclast without rufﬂed border corresponding to the boxed area in inset ﬁgure. Sparse apatite crystals in
the surface zone of Howship's lacuna (asterisk) indicates progressive demineralization of bone matrix by the osteoclast. N nucleus of osteoclast, m mitochondria. The distal
side is shown at the upper side in A and D. The anatomical orientation is shown in A. The scale bars represent 100 μm (A, D, B-inset), 10 μm (B), 2 μm (C), 1 μm (E, F),
500 nm (G).
K. Takeyama et al. / Developmental Biology 394 (2014) 292–304 299
Fig. 6. Origin of osteoclasts and osteoblasts. The double Tg (ﬂi1:GFP/TRAP:DsRed) was employed to examine the locational relationship between osteoclasts and blood
vessels. Magniﬁed views of the areas depicted by the white-dotted rectangles in “A–D” are shown below. Furthermore, osteoblast migration was observed by using a Tg
(osterix:GFP). Magniﬁed views of the white-dotted rectangles in “E–H” are shown below. (A) The early-induced osteoclasts appear at the outside of the blood vessels at day1
after fracturing (a, b, white arrowheads). These osteoclasts are not found inside the blood vessels. Newly generated capillary vessels are observed around the fracture site
(white arrows). (B) The early-induced osteoclasts, which may migrate from the blood vessels in “A”, attach to the bone fragments at day 3 (a, b, white arrowheads). (C) The
late-induced osteoclasts appear at the outside of the blood vessels at day 7 (a, b, white arrowheads). These osteoclasts are also not found inside the blood vessels. (D) By day
12, the late-induced osteoclasts have covered the callus (a, b, white arrowheads). More of these osteoclasts are located inside the ﬁn ray compared with the number of the
early-induced osteoclasts. (E) Osteoblasts that had been present on the ﬁn ray before the fracturing have disappeared by 12 h after it (b, asterisk), whereas on the adjacent ﬁn
ray, the osteoblasts are normally seen at the edge and outer surface of the ﬁn ray (a, white arrow). (F) Osteoblasts on the adjacent ﬁn ray assume an oval shape and migrate to
the fracture site at 24 h (a, b, white arrows). (G) Osteoblasts in the fractured site, which may be migrating from adjacent segments, assume their original round shape at 48 h
(b, white arrows). Osteoblasts, which may be migrating to the fractured site, on the adjacent ﬁn ray are decreased in number, and retain their oval shape (a, white arrows).
Few osteoblasts are observed on the bone fragments away from the ﬁn ray (asterisk). (H) Localization area of osteoblasts spread around the fracture site including the bone
fragments away from ﬁn ray at 72 h (b, white arrow). Few osteoblasts are observed on the adjacent ﬁn ray (a, asterisk) compared with their number in “Aa”. The anatomical
orientation is shown in A. The scale bars represent 100 μm (A–H) and 10 μm (Aa, b, Ba, b, Ca, b, Da, b, Ea, b, Fa, b, Ga, b, Ha, b).
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artery and veins (Fig. 6C and D). These data imply that the
distribution of the unknown factor(s) is different between the
two stages.
To investigate osteoblast induction at the fracture site, we
traced osteoblasts in the early stage of the fracture healing by
using a Tg (osterix:GFP) (Fig. 6E–H). The results showed that the
osteoblasts that had existed on the ﬁn ray before the fracture
disappeared by 12 h after fracturing (Fig. 6Eb, asterisk). In this
stage, osteoblasts on the adjacent ﬁn ray remained in place and
had the normal round shape (Fig. 6Ea, white arrow). At 24 h,
osteoblasts on the adjacent ﬁn ray increased osterix-GFP expres-
sion and became oval in shape toward the fracture site (Fig. 6Fa, b,
white arrows). The shape of the osteoblasts on the fractured site at
48 h returned to their original round shape (Fig. 6Gb, white
arrows), while others on the adjacent ﬁn ray remained an oval
shape (Fig. 6Ga, white arrows). These data suggest that they
migrated toward the fracture site, and some of them were
observed at the fracture site as round-shaped osteoblasts after
the migration. By 72 h, the number of osteoblasts on the fracture
site had increased, and the cells had spread around the fracture
site and bone fragments (Fig. 6Hb, white arrow). In this stage,
few osteoblasts were observed on the adjacent ﬁn ray (Fig. 6Ha,
asterisk). These data indicate that osteoblasts forming the
callus originated from the adjacent ﬁn ray. To conﬁrm osteoblast
migration, live imaging analysis was performed by using Tg
(osterix:GFP). The movie demonstrated that osterix-GFP positive
osteoblasts, especially in the edge region, migrated from adjacent
segments to the fracture site (Supplementary Movie 3). osterix-GFP
positive osteoblasts drastically increased at the fractured site at
72 h. These data suggest that osterix-GFP negative osteoblastic
cells also migrated to the fractured site and differentiated to
osterix-GFP positive. In addition, although the data in Fig. 4Ab
and Cb (yellow arrows) showed the presence of osteoblasts at the
inner surface of the unfractured ﬁn ray, where osteoblasts were
not normally observed, no new bone formation by differentiated
osteoblasts was detected in the unfractured ﬁn ray. Taken together,
our results imply that immature osteoblasts existed on the surface
of the ﬁn ray bone, and suggest that the differentiation factor
secreted in response to the fracturing induced osteoblast differ-
entiation at both the fractured and unfractured ﬁn rays.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.08.007.
In vivo imaging of cox2 expression during the fracture healing
Regarding the factor that induces osteoclasts for bone resorp-
tion and osteoblasts for bone formation, we examined the expres-
sions of cox2 and RANKL mRNAs in the fractured ﬁn ray by using
semi-quantitative RT-PCR (Supplementary Fig. 4A and B). The
results showed that cox2 mRNA was ﬁrst induced at day 3 and
then up-regulated at day 11 after fracturing, and RANKLmRNAwas
up-regulated at day 3. To observe the cox2 activity in vivo, we
generated a new Tg (cox2:GFP) by using the 2.6-kb upstream
region of the cox2 gene (Supplementary Fig. 5A). In the Tg (cox2:
GFP) larvae, cox2-GFP expression was induced by TPA, a chemical
activator of cox2, to conﬁrm whether GFP was indeed induced under
the control of the cox2 promoter. The results obtained by semi-
quantitative RT-PCR showed that TPA strongly induced cox2 expres-
sion with little expression being detected in the control non-treated
ﬁsh (Supplementary Fig. 5B). Consistently, the expression of cox2 and
GFP mRNA in the TPA-treated ﬁsh was detected in the mouth and
gills by RNA in situ hybridization (Supplementary Fig. 5C). These
expression patterns were similar to those of the GFP ﬂuorescent
signals in the TPA-treated Tg (cox2:GFP) (Supplementary Fig. 5D).
To observe cox2 expression during the fracture healing in vivo, we
fractured the Tg (cox2:GFP) ﬁn ray. Before the fracture, GFP signals
were scarcely observed around the ﬁn ray (Fig. 7A). At day 3 after the
fracturing, GFP signals were detected at both sides of the fracture site
(Fig. 7B, black arrowheads). To investigate the localization of these
signals, we performed 3D imaging analysis by using an ALC-stained
specimen of Tg (cox2:GFP) ﬁsh and showed that GFP signals localized
inside the ﬁn ray (Supplementary Fig. 6A). In addition, we generated
the new Tg (ﬂi1:DsRed) by using 4.6-kb upstream region of the ﬂi1
gene (Supplementary Fig. 6B), and crossed with Tg (cox2:GFP) to
generate Tg (cox2:GFP, ﬂi1:DsRed) double transgenic ﬁsh. 3D imaging
analysis of this double Tg demonstrated that cox2-GFP signals were
observed near the blood vessels (Supplementary Fig. 6C, white
arrowheads). Furthermore, histological analysis was performed with
a resin section, and the results revealed that cox2-GFP expressing cells
were localized around the blood vessels (Fig. 7C, black arrowhead).
Inhibition of Cox2 function during fracture healing
To analyze Cox2 function during the fracture healing, we inhibited
Cox2 activity with a chemical inhibitor, CAY10404 in the Tg (TRAP:
DsRed/osterix:GFP). Then we observed the osteoclasts and osteoblasts
induction. The results revealed no signiﬁcant difference in the induc-
tion of the early-induced osteoclasts at day 3 (Fig. 7D, white arrow-
heads) or osteoblasts at day 5 (Fig. 7E, white arrows) between
inhibitor-treated and DMSO-treated control ﬁsh. These results are also
shown statistically by counting the area of the early-induced osteo-
clasts at day 3 or osteoblasts at day 5 (Fig. 7G). However, the formation
of the late-induced osteoclasts at day 11 was strongly impaired in the
inhibitor-treated ﬁsh (Fig. 7F, white arrowheads), and this result is also
shown statistically by counting the area of osteoclasts (Fig. 7G). Taken
together, the region occupied by the late-induced osteoclasts at day 11
in this ﬁsh became statistically smaller than that in the control ﬁsh,
and the lack of these late-induced osteoclasts caused abnormal
fracture healing: the callus became thicker and rougher compared
with the control (Fig. 7H, black arrowheads). These data suggest that
cyclooxygenase-2 activity was necessary to induce the late-induced
osteoclasts for callus remodeling.
Discussion
Analyses of fracture healing have been performed in mamma-
lian models. However, in these models, it is difﬁcult to observe the
cellular behavior in living animal model. In this regard, the small
ﬁsh like medaka and zebraﬁsh can be a strong animal model to
observe living cellular behaviors. Recently, a bone injuring model
by using zebraﬁsh has been reported, indicating that expressions
of the ﬁn regeneration marker genes delay during fracture healing
compared with ﬁn regeneration after amputation (Sousa et al.,
2012). Here, we focus on the cellular behavior of osteoblasts and
osteoclasts, which is essential for having a new knowledge for the
fracture healing. Our established medaka fracture healing model is
the ﬁrst model to permit observation of living osteoblasts and
osteoclasts during fracture healing.
In our analyses, osteoclasts ﬁrstly appeared on the blood vessels,
and then might migrate to the bone fragments or callus. On the other
hand, osteoblasts located on the adjacent ﬁn ray were activated by
the fracturing, and then migrated to the fracture site. To reveal the
molecular mechanisms governing the regulation of osteoblasts and
osteoclasts during fracture healing, we investigated the enzyme
cyclooxygenase-2 (Cox2), which is an inﬂammatory enzyme that
produces prostaglandin E2 (PGE2). To analyze cox2 expression in vivo
during fracture healing, we generated transgenic medaka that
expressed GFP under the control of the medaka cox2 promoter. The
results indicated cox2 to be essential for the late-induced osteoclasts
during bone remodeling.
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Fig. 7. cox2 expression and function during the fracture healing. (A) Fluorescent image of the fracture site of a Tg (cox2:GFP) at the day of fracturing (day 0). No signiﬁcant
GFP signals are observed in the ﬁn ray. (B) Fluorescent image of the fracture site at day 3 after fracturing. cox2-GFP positive cells (black arrowheads) are observed at both
sides of the fracture site. (C) Cross-section at the level of the black-dotted line in “B”. Red dotted-circle indicates the typical vascular wall in which hematopoietic cells are
observed. cox2-GFP positive cells are observed near the blood vessels inside the ﬁn ray (black arrowhead). (D–F) A double Tg (osterix:GFP/TRAP:DsRed) was treated with 1 μm
CAY10404, a Cox2 inhibitor. (D) The early-induced osteoclasts at day 3 after fracturing (white arrowheads). There is no signiﬁcant difference in the formation of the early
induced-osteoclasts between the non-treated (DMSO only) control ﬁsh and inhibitor-treated (CAY10404 dissolved in DMSO) ﬁsh. (E) Callus formation at day 5. The induction
of osteoblasts is also normal in both control and inhibitor-treated ﬁsh (white arrows). (F) The late-induced osteoclasts at day 11. The induction of the late-induced osteoclasts
is impaired in the inhibitor-treated ﬁsh, compared with that in the non-treated ﬁsh (white arrowheads). (G) Quantitative analysis of the osteoclasts and osteoblasts area. The
results are shown as the mean7standard deviation (control: n¼3, cay10404: n¼4). The asterisk indicates signiﬁcant difference at po0.01 and NS represents no signiﬁcant
difference at po0.05 as compared with the control. (H) Bone staining at day 25. The insufﬁcient number of late-induced osteoclasts in the inhibitor-treated (CAY10404
dissolved in DMSO) ﬁsh causes abnormal fracture healing compared with that in the non-treated (DMSO only) one (black arrowheads). The anatomical orientation is shown
in A and C. The left side is shown at the upper side in C. The scale bars represent 100 μm (A–C) and 200 μm (D–F, H).
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During the fracture healing process, osteoclasts and osteoblasts
play important roles: osteoblasts form the callus to cover the
fracture site, whereas osteoclasts are induced before and after the
callus formation to resorb bone fragments out of the ﬁn ray or
the callus. In these stage-speciﬁc osteoclasts, the phenotype of the
early-induced osteoclast was different from that of the late-
induced one. The former, which was localized on the sharp bone
fragments, was smaller in size and showed low TRAP-activity.
Moreover, it showed no typical rufﬂed border and clear zone, as
determined by TEM, which similar phenotype is observed in some
chondroclasts (Knowles et al., 2012; Ota et al., 2009). On the other
hand, the late-induced osteoclasts were larger and showed high
TRAP activity. No typical rufﬂed border was identiﬁed, but the
clear zone was detected by TEM. This morphology resembles that
of the osteoclasts in the neural and hemal arches (Chatani et al.,
2011). They covered the thick and rough callus. This morphological
difference reﬂected their function: the early-induced osteoclasts
were highly mobile in order to move around the fracture site. On
the other hand, the late-induced osteoclasts had a strong adhesive
property allowing them to seal the resorbing site for remodeling of
the thick and rough callus. In the mammalian models, osteoclasts
also appear at two stages during the process of fracture healing
(Schindeler et al., 2008). In this analysis, the ﬁrst osteoclast
appears just after cartilage formation, which cells are sometimes
called chondroclasts; and the second, after bone formation to
remodel with their rufﬂed border and sealing zone. It is also
thought that osteoclasts functioning in the ﬁrst stage overlap with
macrophages, because the callus formation remains normal when
osteoclast differentiation is inhibited (Flick et al., 2003; Ulrich-
Vinther and Andreassen, 2005; Ulrich-Vinther et al., 2005). In
contrast, our early-induced osteoclasts appeared just after fractur-
ing, which stage is different from that of chondroclasts; though the
cell phenotype looks similar. We must raise the following ques-
tion: how do these osteoclasts appear without damage of blood
vessels? To answer this question, further experiments are required
for osteoclast progenitors that may get out of blood vessels, and
become mature on the way to the fractured fragments.
Both types of osteoclasts appeared near but not on the
fractured fragments or the callus, suggesting that they had
differentiated by paracrine signaling. In this study, we examined
cox2 that produces a paracrine factor for induction of osteoclast
differentiation, because cox2-deﬁcient mice show an impaired
fracture healing phenotype due to abnormal endochondral ossiﬁ-
cation (Simon et al., 2002). However, the cellular function of cox2
during fracture healing remains obscure, because these cox2-
deﬁcient mice exhibit increased perinatal mortality associated
with various abnormalities (Dinchuk et al., 1995; Morham et al.,
1995). In the medaka model, we succeeded in visual tracing of the
later induction of cox2 by using the cox2 promoter Tg medaka.
During the fracture healing, perivascular cells expressed cox2
starting at day 3 after fracturing; and the lack of functional Cox2
due to inhibitor treatment impaired the late-induced osteoclasts.
However, gathering of the osteoblasts at day 5 after fracturing
seemed to remain normal, although no further effect of Cox2 on
osteoblasts was examined. Our study suggests that cox2 expression
by the perivascular cells may be important for osteoclast differentia-
tion. Regarding the comparison of fracture healing with ﬁn regen-
eration, we cannot restore the fracture site into the original structure
by 2 months, although in medaka ﬁn ray regeneration, ﬁn is almost
regenerated after 10 days (Katogi et al., 2004). In this point of the
time course of fracture healing, medaka ﬁn fracture that is different
from ﬁn regeneration, is similar to the mammalian bone fracture
healing, which is consistent with the observation of the zebraﬁsh
bone crush injury model (Sousa et al., 2012).
As to the relationship between osteoclasts and osteoblasts in
the fracture healing, the live imaging clearly showed the strict
communication between osteoblasts and osteoclasts: after the
disappearance of the early-induced osteoclasts, osteoblasts
appeared to perform the callus formation, and then just after their
disappearance, the late-induced osteoclasts appeared for remodel-
ing of the bone. Such concurrent action would require some
soluble factor performing coordinate activation of osteoclasts
and osteoblasts in a time-dependent manner. For callus formation,
osteoblasts are recruited from the adjacent ﬁn ray, which surface
might be covered with layered osteoblastic cells. Some fracture
signals activate these osteoblastic cells on the surface of ﬁn ray,
then these activated cells may recognize the fracture site and
migrate while they differentiate into mature osteoblasts. The
activation and differentiation system of osteoblasts from progeni-
tors on ﬁn ray is investigated in close future.
Finally, our developed medaka model potentially gives new
insights into the molecular mechanisms at play in the healing of
bone fractures.
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